Related Experiment Video
Updated: Jun 26, 2026

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity
Hiroyuki Nishikawa1, Wenwen Wu, Ayaka Koike
1Division of Breast and Endocrine Surgery, Institute of Advanced Medical Science, and Department of Radiology, St. Marianna University School of Medicine, Kawasaki, Japan.
Abstract:
The breast and ovarian tumor suppressor BRCA1 constitutes a RING heterodimer E3 ligase with BARD1. BRCA1-associated protein 1 (BAP1) is a ubiquitin COOH-terminal hydrolase that was initially identified as a protein that bound to the RING finger domain of BRCA1. However, how BAP1 contributes to the E3 activity of BRCA1/BARD1 is unclear. Here, we report that BAP1 interacts with BARD1 to inhibit the E3 ligase activity of BRCA1/BARD1. Domains comprised by residues 182-365 of BAP1 interact with the RING finger domain of BARD1, and surface plasmon resonance spectroscopy (BIAcore) analyses showed that BAP1 interferes with the BRCA1/BARD1 association. The perturbation resulted in inhibition of BRCA1 autoubiquitination and NPM1/B23 ubiquitination by BRCA1/BARD1. Although BAP1 was capable of deubiquitinating the polyubiquitin chains mediated by BRCA1/BARD1 in vitro, a catalytically inactive mutant of BAP1, C91S, still inhibited the ubiquitination in vitro and in vivo, implicating a second mechanism of action. Importantly, inhibition of BAP1 expression by short hairpin RNA resulted in hypersensitivity of the cells to ionizing irradiation and in retardation of S-phase progression. Together, these results suggest that BAP1 and BRCA1/BARD1 coordinately regulate ubiquitination during the DNA damage response and the cell cycle.
Insights
BRCA1-associated protein 1 (BAP1) inhibits BRCA1/BARD1 E3 ligase activity, impacting DNA damage response and cell cycle progression. BAP1 plays a crucial role in regulating ubiquitination pathways critical for genomic stability.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- BRCA1, a tumor suppressor, forms a RING heterodimer E3 ligase with BARD1.
- BRCA1-associated protein 1 (BAP1) is a deubiquitinating enzyme that interacts with BRCA1.
- The precise role of BAP1 in the E3 ligase activity of BRCA1/BARD1 remains unclear.
Purpose of the Study:
- To elucidate the mechanism by which BAP1 influences the E3 ligase activity of the BRCA1/BARD1 complex.
- To investigate the functional consequences of BAP1's interaction with BRCA1/BARD1 in cellular processes.
- To determine BAP1's role in DNA damage response and cell cycle regulation.
Main Methods:
- Protein interaction studies using domains of BAP1 (residues 182-365) and the BARD1 RING finger domain.
- Surface plasmon resonance (BIAcore) to analyze BAP1's effect on BRCA1/BARD1 association.
- In vitro ubiquitination assays with BRCA1/BARD1 and BAP1 (wild-type and C91S mutant) on substrates like NPM1/B23.
- In vivo studies using short hairpin RNA (shRNA) to inhibit BAP1 expression and assess cellular responses to ionizing irradiation and cell cycle progression.
Main Results:
- BAP1 directly interacts with BARD1, inhibiting the E3 ligase activity of the BRCA1/BARD1 complex.
- BAP1 binding disrupts the BRCA1/BARD1 association, leading to reduced BRCA1 autoubiquitination and NPM1/B23 ubiquitination.
- BAP1 exhibits in vitro deubiquitinating activity and also inhibits ubiquitination via a catalytically independent mechanism.
- Depletion of BAP1 sensitizes cells to ionizing irradiation and causes S-phase progression defects.
Conclusions:
- BAP1 acts as a negative regulator of BRCA1/BARD1 E3 ligase activity through direct interaction with BARD1.
- BAP1 employs dual mechanisms: enzymatic deubiquitination and non-enzymatic inhibition of ubiquitination.
- BAP1 and BRCA1/BARD1 function coordinately in regulating ubiquitination for DNA damage response and cell cycle control.
Related Concept Videos
Restarting Stalled Replication Forks
Inhibition of Cdk Activity
Inhibition of CDK Activity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules

